Due to the emergence of wide-spread infectious diseases, there is a heightened need for antimicrobial and/or antifouling coatings that can be used to prevent infection and transmission in a variety of applications, ranging from healthcare devices to public facilities. While antimicrobial coatings kill pathogenic bacteria upon contact with the surface, the antimicrobial function alone often lacks long-term effectiveness due to the accumulation of dead cells and their debris on the surface, thus reducing the performance of the coating over time. Therefore, it is desirable to develop coatings with the dual functions of antimicrobial efficacy and fouling resistance, in which antifouling coatings provide the added benefit of preventing the adhesion of dead cells and debris. Leveraging the outstanding antifouling properties of zwitterionic coatings, we synthesized copolymers with this antimicrobial-antifouling dual function by immobilizing lysozyme, a common antimicrobial enzyme, to the surface of a pyridinium-based zwitterionic copolymer. Specifically, poly(4-vinylpyridine- co -pentaflurophenyl methacrylate- co -divinyl benzene) [P(4VP-PFPMA-DVB)] thin films were synthesized by an all-dry vapor deposition technique, initiated Chemical Vapor Deposition, and derivatized using 1,3-propane sultone to obtain sulfobetaine moieties. Lysozyme, known to hydrolyze polysaccharides in the cell wall of Gram-positive bacteria, was immobilized by forming amide bonds with the copolymer coating via nucleophilic substitution of the pentafluorophenyl group. The antifouling and antibacterial performance of the novel lysozyme-zwitterionic coating was tested against Gram-positive Bacillus subtilis and Gram-negative Pseudomonas aeruginosa . A reduction in surface adhesion of 87% was achieved for P. aeruginosa , and of 75% for B. subtilis , when compared to a common poly(vinyl chloride) surface. The lysozyme-zwitterionic coating also deactivated 67% of surface-attached Gram-positive bacteria, B. subtilis . This novel dual-function material can produce anti -infection surfaces for medical devices and surgical tools, personal care products, and surfaces in public facilities.
more »
« less
Toward Universal Photodynamic Coatings for Infection Control
The dual threats posed by the COVID-19 pandemic and hospital-acquired infections (HAIs) have emphasized the urgent need for self-disinfecting materials for infection control. Despite their highly potent antimicrobial activity, the adoption of photoactive materials to reduce infection transmission in hospitals and related healthcare facilities has been severely hampered by the lack of scalable and cost-effective manufacturing, in which case high-volume production methods for fabricating aPDI-based materials are needed. To address this issue here, we examined the antimicrobial efficacy of a simple bicomponent spray coating composed of the commercially-available UV-photocrosslinkable polymer N -methyl-4(4'-formyl-styryl)pyridinium methosulfate acetal poly(vinyl alcohol) (SbQ-PVA) and one of three aPDI photosensitizers (PSs): zinc-tetra(4- N -methylpyridyl)porphine (ZnTMPyP 4+ ), methylene blue (MB), and Rose Bengal (RB). We applied these photodynamic coatings, collectively termed SbQ-PVA/PS, to a variety of commercially available materials. Scanning electron microscopy (SEM) and time-of-flight secondary ion mass spectrometry (ToF-SIMS) confirmed the successful application of the coatings, while inductively coupled plasma-optical emission spectroscopy (ICP-OES) revealed a photosensitizer loading of 0.09-0.78 nmol PS/mg material. The antimicrobial efficacy of the coated materials was evaluated against methicillin-susceptible Staphylococcus aureus ATCC-29213 and human coronavirus strain HCoV-229E. Upon illumination with visible light (60 min, 400-700 nm, 65 ± 5 mW/cm 2 ), the coated materials inactivated S. aureus by 97-99.999% and HCoV-229E by 92-99.999%, depending on the material and PS employed. Photobleaching studies employing HCoV-229E demonstrated detection limit inactivation (99.999%) even after exposure for 4 weeks to indoor ambient room lighting. Taken together, these results demonstrate the potential for photodynamic SbQ-PVA/PS coatings to be universally applied to a wide range of materials for effectively reducing pathogen transmission.
more »
« less
- NSF-PAR ID:
- 10292273
- Date Published:
- Journal Name:
- Frontiers in Medicine
- Volume:
- 8
- ISSN:
- 2296-858X
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
-
more » « less
Abstract Antibacterial coatings can prevent and treat medical device‐associated infections. We examined the antibacterial properties of coatings assembled from poly‐
l ‐lysine (PLL) and hyaluronic acid (HA). PLL/HA films were fabricated using layer‐by‐layer assembly with three different PLL MWs, differentiated by number of repeat units, that is, 33, 91, and 407 (denoted by PLL30, PLL90, and PLL400). Films assembled with all three PLL MWs completely inhibited the growth of planktonic, gram‐positiveStaphylococcus aureus S. aureus Pseudomonas aeruginosa andEscherichia coli S. aureus S. aureus S. aureus -
more » « less
Abstract Aims Due to antibiotic tolerance of microbes within biofilm, non-antibiotic methods for prevention and treatment of implant-related infections are preferable. The goal of this work is to evaluate a facile loading strategy for medium-chain fatty-acid signaling molecules 2-heptycyclopropane-1-carboxylic acid (2CP), cis-2-decenoic acid (C2DA), and trans-2-decenoic acid, which all act as diffusible signaling factors (DSFs), onto titanium surfaces for comparison of their antimicrobial efficacy.
Methods and results Titanium coupons were drop-coated with 0.75 mg of DSF in ethanol and dried. Surface characteristics and the presence of DSF were confirmed with Fourier Transform infrared spectroscopy, x-ray photoelectron spectroscopy, and water contact angle. Antimicrobial assays analyzing biofilm and planktonic Staphylococcus aureus, Escherichia coli, or Candida albicans viability showed that planktonic growth was reduced after 24-h incubation but only sustained through 72 h for S. aureus and C. albicans. Biofilm formation on the titanium coupons was also reduced for all strains at the 24-h time point, but not through 72 h for E. coli. Although ∼60% of the loaded DSF was released within the first 2 days, enough remained on the surface after 4 days of elution to significantly inhibit E. coli and C. albicans biofilm. Cytocompatibility evaluations with a fibroblast cell line showed that none of the DSF-loaded groups decreased viability, while C2DA and 2CP increased viability by up to 50%.
Conclusions In this study, we found that DSF-loaded titanium coupons can inhibit planktonic microbes and prevent biofilm attachment, without toxicity to mammalian cells.
-
Abstract We synthesized novel TiO2/ZnO-phosphate (TP/ZP) and polymethyl hydrogen siloxane (PMHS)-based two-layer hydrophobic coatings with potential antimicrobial properties tuned for application on steel substrates. The mathematical method of topological data analysis was applied to surface roughness data. Wetting characterizations showed stable hydrophobic behavior of the two-layer coated samples. Through tribological characterization, we compared the friction behavior of uncoated steel samples and steel samples coated with different coating materials. The coefficient of friction of uncoated base materials (ranging from 0.221 to 0.269) and the two-layer hydrophobic coatings (ranging from 0.234 to 0.273) indicated that the coatings confer hydrophobic properties to the substrates without a notable change in the friction behavior. We observed the correlations between the wetting and friction behaviors and the average roughness of the coated samples. Analysis of the micrographs of the scratched surfaces revealed preliminary information about the durability and abrasion resistance of the coatings.more » « less
-
null (Ed.)Musculoskeletal conditions such as low back pain, arthritis and other diseases of the joints affect millions of people around the world and are one the leading causes of disability (1). These diseases often require surgery, including total joint replacement in cases of deterioration of the natural joint (2). Serious concern regarding such procedure is the bacteria adhesion and proliferate on the surfaces of these orthopedic implants. Moreover, bacteria have shown the ability to generate resistance against drugs that once could kill them, hence, being more difficult or even impossible to eliminate them. These pathogens are the principal causative agents of two major types of infection in bone: septic arthritis and osteomyelitis, which involve the inflammatory destruction of joint and bone (3). Therefore, there is an unmet need to generate materials capable of showing reduced bacterial adhesion as well as bactericidal effect in order to avoid further health complications. nanoSUS Bio-Tech was founded based on a collaboration between Komatsuseiki Kosakusho Co., Ltd (KSJ:Japan) and Northeastern University (NEU) in 2019. KSJ has been developing ultra-fine-grained stainless steel since 2002 (4, 5). Using this technology, we are able to control the grain size without any changes in the chemical composition of commercially available FDA approved stainless steel. On the other hand, Thomas J. Webster’s lab has achieved the ability to decrease bacteria adhesion and growth with and without the use of antibiotics, for nanostructured surfaces. As an outcome of this collaboration, we were able to manufacture high strength ultra-fine-grained stainless steel with antimicrobial surface. The global orthopedic implants market was estimated at $45.90 billion in 2017 and is expected to reach at $66.63 billion by 2025, registering a CAGR of 4.7% from 2018 to 2025 (6), due to the growing demand by increasing geriatric population, rising incidence of spine illness and technological advancements in this field. Based on geography, North America accounted for nearly half of the total market revenue in 2017 and is anticipated to retain its top status till 2025. At the same time, the Asia-Pacific region would cite the fastest CAGR of 6.4% throughout the study period. Based on current market trends, companies such as Zimmer, Stryker, S&N, Depuy, J&J, and Medtronic are our target customers. Currently, we are expanding our network in the US by becoming member of Center for Disruptive Musculoskeletal Innovations (CDMI). Moreover, this project is funded through CDMI NSF program that will aid to expand the collaboration between KSJ and NEU. The company will be established by financing from KSJ, in Boston, MA. It will manage the collaborations between academia, marketing consultants and lawyers in the US, and directors and researchers in Japan and the US. We are expecting to start our sales from the beginning of 2021.more » « less
- Free Publicly Accessible Full Text
-
Accepted Manuscript1.0
- Journal Article:
- https://doi.org/10.3389/fmed.2021.657837
